Loading chat...
IN SB0461
Bill
AI Summary
SB 461 Summary
-
Adds blood glucose monitoring (non-invasive capillary sampling) to the definition of basic life support procedures effective July 1, 2015.
-
Establishes a syringe exchange program framework allowing local health departments, municipalities, and approved nonprofits to operate programs in counties where a public health emergency has been declared for hepatitis C or HIV transmitted through intravenous drug use.
-
Requires programs to annually register with the state department, maintain medical oversight by licensed physicians/nurses/physician assistants, provide drug treatment information and overdose response training, and file quarterly reports without collecting personally identifiable information.
-
Prohibits law enforcement from stopping, searching, or seizing individuals based on program attendance and bars program participation from establishing probable cause.
-
Makes syringe exchange programs expire July 1, 2019, and exempts qualified entities distributing syringes from drug paraphernalia laws; establishes an interim study committee to review needle/syringe exchange programs and related criminal penalties by November 1, 2015.
Legislative Description
Health matters. Amends the definition of "basic life support" to include blood glucose monitoring. Authorizes the state department of health (state department) to enter into partnerships to encourage best practices in: (1) identification and testing of populations at risk of disease related to illegal drug use; and (2) the health care treatment of incarcerated individuals for conditions related to illegal drug use. Authorizes the state health commissioner to declare a public health emergency. Specifies that hospital discharge information filed with the state department is confidential except under specified circumstances. Sets forth conditions in which a local health department, a municipality,
Last Action
Public Law 208
5/5/2015